MARCO and neoplasm: In NSCLC, early in tumor formation, tissue-resident macrophages displaying the M2-like features, CD206 and MARCO, were shown to promote tumor cell epithelial–mesenchymal transition (EMT), invasiveness and to induce a Treg cell response that limits anticancer adaptive immunity [37].